GlassScriptPhysician profile
Jeremie Axe
NPI 1093979692
$179,040.80
in general payments reported to CMS, 2019-2025
29 companies · $39K in 2025
The $39K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $2,686 · 2021: $15K · 2022: $29K · 2023: $29K · 2024: $23K · 2025: $39K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $8,077 · Travel and Lodging: $5,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $54,502.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,752.80 |
| Food and Beverage | $8,076.96 |
| Travel and Lodging | $5,723.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $117,452.17 | 2019-2025 | Arthrex, Arthroplasty Implants Anatomic Total Shoulder Eclipse, Shoulder Implants Speedbridge Peek Anchors |
| Wright Medical Technology, INC. | $39,399.70 | 2019-2020 | |
| Liberty Surgical INC. | $5,414.31 | 2019-2022 | |
| Medical Device Business Services, INC. | $5,006.86 | 2025 | Inhance |
| Eclipse Technology Solutions INC. | $4,077.31 | 2022-2025 | |
| Stryker Corporation | $1,596.47 | 2019-2025 | Mako, Citrefix |
| Smith+Nephew, INC. | $1,340.49 | 2019-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Na, Bone Anchors With Arthroscopic Delivery System |
| Davol INC. | $897.59 | 2020-2025 | Arista Ah Flexitip, Arista, Avitene Ultrafoam |
| Horizon Therapeutics Plc | $878.05 | 2019-2022 | |
| Pacira Therapeutics, INC. | $552.19 | 2019-2021 | |
| Depuy Synthes Sales INC. | $485.49 | 2019-2022 | |
| Integrity Orthopaedics, INC. | $458.86 | 2023-2024 | Integrity Orthopaedics |
| Zimmer Biomet Holdings, INC. | $267.59 | 2021-2024 | Comprehensive Shoulder System, Quattro, Tapestry |
| Zynex Medical, INC. | $228.08 | 2023 | Nexwave |
| Baxter Healthcare | $126.05 | 2023-2025 | Tisseel, Perclot |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $124.03 | 2024-2025 | Exparel, Zilretta, Iovera |
| Axogen | $122.30 | 2024-2025 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Medacta USA, INC. | $109.65 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $102.50 | 2025 | Velys |
| Conformis, INC. | $94.00 | 2021 | |
| Bioventus LLC | $93.41 | 2019-2025 | Bonescalpel & Sonicone (O.R.), Bonescalpel, Durolane |
| Becton, Dickinson and Company | $46.18 | 2022 | |
| Embody, INC. | $40.07 | 2023 | |
| Fx Shoulder Solutions, INC | $34.34 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $31.90 | 2025 | |
| Kci USA, INC. | $16.89 | 2023 | Prevena, Prevena Restor Rotoform, Activ.A.C. |
| Ferring Pharmaceuticals INC. | $16.38 | 2019 | |
| Pfizer INC. | $16.24 | 2023 | |
| Synergy Orthopedics, LLC | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremie Axe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.